BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 10956195)

  • 1. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
    van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
    J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomers.
    DeWald HA; Heffner TG; Jaen JC; Lustgarten DM; McPhail AT; Meltzer LT; Pugsley TA; Wise LD
    J Med Chem; 1990 Jan; 33(1):445-50. PubMed ID: 1967318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
    Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D3 agonists disrupt social behavior in rats.
    Kagaya T; Yonaga M; Furuya Y; Hashimoto T; Kuroki J; Nishizawa Y
    Brain Res; 1996 May; 721(1-2):229-32. PubMed ID: 8793104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Dopamine D
    Huang M; He W; Kiss B; Farkas B; Adham N; Meltzer HY
    J Pharmacol Exp Ther; 2019 Nov; 371(2):517-525. PubMed ID: 31511365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels.
    De Boer P; Enrico P; Wright J; Wise LD; Timmerman W; Moor E; Dijkstra D; Wikström HV; Westerink BH
    Brain Res; 1997 May; 758(1-2):83-91. PubMed ID: 9203536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.
    Koeltzow TE; Xu M; Cooper DC; Hu XT; Tonegawa S; Wolf ME; White FJ
    J Neurosci; 1998 Mar; 18(6):2231-8. PubMed ID: 9482807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907].
    Witkin JM; Dijkstra D; Levant B; Akunne HC; Zapata A; Peters S; Shannon HE; Gasior M
    J Pharmacol Exp Ther; 2004 Mar; 308(3):957-64. PubMed ID: 14711932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adenosine A(2A) receptor stimulation in vivo on dopamine D3 receptor agonist binding in the rat brain.
    Hillefors M; Hedlund PB; von Euler G
    Biochem Pharmacol; 1999 Dec; 58(12):1961-4. PubMed ID: 10591151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
    Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptors.
    Witkin JM; Levant B; Zapata A; Kaminski R; Gasior M
    J Pharmacol Exp Ther; 2008 Sep; 326(3):930-8. PubMed ID: 18566292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907.
    Witkin J; Gasior M; Acri J; Beekman M; Thurkauf A; Yuan J; DeBoer P; Wikström H; Dijkstra D
    Eur J Pharmacol; 1998 Apr; 347(2-3):R1-3. PubMed ID: 9741997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.
    Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME
    Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
    Acquas E; Di Chiara G
    Eur J Pharmacol; 1999 Oct; 383(2):121-7. PubMed ID: 10585525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine sensitization prevents the hypolocomotor effects of high but not low doses of PD 128,907.
    Prinssen EP; Koek W; Kleven MS
    Eur J Pharmacol; 1998 Aug; 355(1):19-22. PubMed ID: 9754934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the dopamine D3 antagonist PD 58491 and its interaction with the dopamine D3 agonist PD 128907 on brain dopamine synthesis in rat.
    Whetzel SZ; Shih YH; Georgic LM; Akunne HC; Pugsley TA
    J Neurochem; 1997 Dec; 69(6):2363-8. PubMed ID: 9375667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.